|Agritech Capital||North Carolina, United States, Wilmington|
|Business Online Public Company||Bangkok, Krung Thep, Thailand|
|Criabiz Ventures||Brazil, São Paulo, Sorocaba|
|Elephant Capital||England, London, United Kingdom|
|Evonik Venture Capital||Germany, Hanau, Hessen|
|Fortum||Boston, Massachusetts, United States|
|GENIUS Venture Capital||Germany, Mecklenburg-Vorpommern, Schwerin|
|Independence Equity||Illinois, Northbrook, United States|
|Millennium Management||New York, New York, United States|
|Qifu Capital Management||China, Guangdong, Shenzhen|
|Rongsheng Huitong||Beijing, China, Pinggu|
|Ruby Capital||Central, Central Region, Singapore|
|Sora Ventures||China, Hong Kong, Hong Kong Island|
|Starter Studio||Florida, Orlando, United States|
|Table Mountain Ventures||New York, New York, United States|
|VeriSign||Bluemont, United States, Virginia|
|Western Economic Diversification Canada||Alberta, Canada, Edmonton|
|YSS Capital||Central, Central Region, Singapore|
|$130M||16 Sep 2021||Boston, Massachusetts, United States|
|$100M||28 Apr 2021||Boston, Massachusetts, United States|
|$20M||11 Jun 2018||Boston, Massachusetts, United States|
– Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced a $30m extension to its Series C funding round.
– The round was led by PFM Health Sciences with participation from ProAssurance, Harmonix, and existing investors such as the Relyens Group and IPF Partners.
– That round also included investments from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, and Surgical.AI.
– The funding will be used to continue developing its platform as well as advance new data solutions that support value-based care providers.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.